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lood tests from a clinical laboratory are generally reported on
a form that shows the result and , next to it, a normal range .
This form has the apparent advantages of being direct, simple,
and easy to use. But in fact , it is none of these , and failure by physicians to understand the significant underlying assumptions behind the
concept of normal range leads to some awful consequences in patient
care. Beyond that, lack of understanding of the same assumptions by
lawmakers and the regulation-writing bureaucrats who follow behind
them leads to terrible stupidities that threaten to institutionalize improper medical practices.
I recently have been involved in two topical, that is to say (with
academic hyperbole), intensely controversial examples of abuse of the
concept of normal range. In one case a child su_ffered being born with
the prospect of certain death in infancy . In such situations the human
issues never really are resolved. But the scientific , social, and economic
aspects of the case were discussed in a court of law. During the legal
procedings I was one of several "expert" witnesses asked to testify. In
the second instance, new legislation is being implemented which is likely
to worsen the very problem it ostensibly addresses. The problem relates
to the manner in which physicians distinguish between health and
disease. As a pathologist, it is my business first to identify the signs
of ill health, and second to alert a patient's attending physician to the
presence of dangerous or potentially dangerous findings. Therefore, the
legislation of which I speak affects me directly, as well as every other
pathologist in every hospital in the country. More important, it affects
the utilization of diagnostic procedures which in human terms can
translate into continued life or death of patients. Both cases were
precipitated by a failure to examine the implications of the concept of
normal range beyond the most superficial impression it conveys. This
concept is taught in medical school but is readily within the grasp of
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any generally educated person who may profit as a patient, or a citizen,
from such understanding.

Tay-Sachs test results and the normal range
Among the most impressive and valuable achievements in medical
diagnosis is the ability to detect the carrier state for Tay-Sachs disease
in prospective parents. With a specimen of blood from the arm and
a sophisticated chemical test in the clinical laboratory a couple can know
whether they are at no risk or have a 2 5 % chance of giving birth to
an afflicted child .
Tay-Sachs disease is an inherited disorder characterized by the inexorable accumulation of an abnormal metabolite, the GM 2 ganglioside,
in brain cells of afflicted newborns. It produces in infants a degenerative
disorder that is manifested by a failure to grow, mental retardation,
blindness, loss of voluntary motor ability, and death by the age of three
or four. The ganglioside is normally metabolized by two enzymes, hexosaminidase A and B (hex A and B). Newborns with Tay-Sachs have
almost no hex A. To express this trait, the newborn must be homozygous
for the defective gene (it must therefore have inherited a recessive gene
from each of its parents). The parents are thus both heterozygous for
the gene, meaning that they possess a normal gene paired with the defective one. The normal gene is "dominant," meaning that the trait is
not expressed . The recessive gene is not revealed by abnormal signs or
symptoms . But such an individual is a carrier, and if two carriers mate
they transmit their genes according to simple Mendelian patterns.
If either parent is not a carrier of the recessive gene, their offspring
could not possibly be homozygous and express the disease . If both
parents are heterozygous , then one in four times their offspring will
be homozygous for the Tay-Sachs gene and. express the full disorder,
two in four times it will be heterozygous, and one in four times the
child will not inherit the gene from either parent.
Although no outward evidence of the carrier state is apparent, a
laboratory test has been developed which segregates homozygous normals, heterozygous Tay-Sachs carriers, and homozygous TaySachs-afflicted subjects . 1 The value of knowing the results of such a
test is obvious.
The laboratory test can also be performed on amniocentesis fluid from
a pregnancy occurring as the result of a union of heterozygous carriers.
It can determine whether the fetus will express the full-blown disease
or not. The choice of abortion is then available. A couple with this
knowledge can attempt again to produce a healthy baby with a 75%
chance of doing so. Their success can be confirmed by application of
the same test procedure.
To prevent the birth of Tay-Sachs children, a series of events must
fall into place. A couple must seek testing or be advised to have it.
The laboratory tests must be done properly. They must be interpreted
properly. All subsequent diagnostic and therapeutic steps must be properly executed under expert medical guidance. While all this does not
seem so problematic, in fact, Tay-Sachs children continue to be born.
Most often such occurrences do not follow from the desire of parents
to complete the pregnancy with the outcome known to them in advance , but because of a breakdown somewhere in the sequence.
Tay-Sachs disease appears among Ashkenazi Jews with a frequency
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of 1 in 900 births. The recessive gene conferring carrier status exists in
1 out of 30 adults of such origin (1 I 30 x 1 I 30 = 900). In the general
population, its frequency is vastly lower. The carrier rate, for example,
is estimated at 1 in 300 non-Jewish Americans, and therefore the frequency ofTay-Sachs offspring from that population is only 1 in 90,000
(11300 x 11300 = 1190,000). 2 The Jewish population has therefore
been identified as being at a relatively high risk . Attempts are made
to test Jewish couples by alerting physicians to their special risk status
and by going directly to the people themselves in programs operated
through synagogues. This approach is considered to be more or less adequate in the United States. Given the relative rarity of the disease, the
cost-benefit ratio is thought to be too low to justify testing the broad
base of the population . Whether it is or not could be debated. There
is little argument for mandatory testing for Tay-Sachs in, for example,
the People's Republic of China. Yet the disorder is known there3 and
interest in it is widespread .4 Doctors there are curious about the dispersion of the once flourishing communities of Chinese Jews in Kai-fengfu, Tungming, and Sungchiang, later subsumed into the Han majority and thus not overtly identifiable for more than sixty years. >

The case in point
In one celebrated case the neat working of the diagnostic and
therapeutic program broke down in a most unexpected place-in the
interpretation of the laboratory test results vis-a-vis the quoted normal
range . As a consequence of a failure to understand this concept, two
inauspicious births occurred . One was of an afflicted child. The other
was of a new legal basis for malpractice suits, the cause of action being
''wrongful life.'' Reporting of the case in both lay and medical literature
has either ignored or failed to deal properly with the fundamental abuse
of the normal range concept that gave rise to the unfortunate consequences in the first place.
The facts of the case are as follows . A couple in southern California
decided to conceive a child. Both were descendants of Eastern European Jews. Having learned of their high-risk status from a communitydirected educational campaign they themselves initiated the request for
carrier status testing by going to their family physician. He authorized
blood testing and referred them to the modest clinical laboratory in
his medical office building . The specialized test was not performed by
that laboratory, but specimens were drawn there and sent to a larger
reference laboratory in the same city. Each specimen was tested and
the results were returned to the originating laboratory, which transmitted
them to the physician.
The form for the results of this test is more complicated than those
of more common tests, but the format is essentially the same. The
analytic results are reported , the normalrange is quoted, and notes are
made which help the physician interpret the results.
The reports in this case gave the information shown in Table 1 (all
names, demographics, specific identification numbers, dates, and other
miscellaneous requirements of a complete laboratory report are omitted). On the basis of this information the family physician told the
couple that the wife could not be a Tay-Sachs carrier and, therefore,
that they need have no fear of conceiving a Tay-Sachs child. Pregnancy
occurred. The obstetrician accepted the verbal assurance of the couple
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that they were at no risk . He did not review the results, discuss the testing
with the family physician, or request confirmatory testing. A Tay-Sachs
child was born. Within the appropriate time, a malpractice suit was
brought on behalf of the child on the basis of' 'wrongful life.'' In other
words, the child was suing for having been born. The suit named the
physicians and the laboratories.
It is helpful to draw attention to the aspect of this report that is most
important for assessment of carrier status, viz, the result "hexosaminidase A, % of total." The "hexosaminidase, total" is not so
valuable because of the very wide , overlapping ranges between controls,
heterozygotes, homozygotes, and individuals with other conditions .
Only the percent of total result provides some discrimination between
the populations of interest. The husband's percent of total result places
him squarely in the middle of the heterozygote's range. The wife's percent of total result is at the very lower limit of the range given for
controls. 6

!he limits. of the normal range and data
mterpretanon

Since the ultimate outcome differed from the intended one , it is
reasonable to inquire where the error occurred. The issue is, What is
the proper way to think about results very close to the quoted normal
range limit?
TABLE 1
EDITED COMPOSITE REPORT OF TESTS
FOR TAY-SACHS CARRIER STATUS
Patient Name : Husband

Referring Physician : Dr. XYZ

Test

Result

Serum hexosaminidase,
total
Serum hexosaminidase A

Units

Adult normals

980
38

nmol!ml!hr
% of total

See " Ranges"
below

360
50

nmol!ml!hr
% of total

See "Ranges"
below

6. O'Brien et al. , " Tay-Sachs
Disease ,' ' on which the report form is
based , prese nted total hexosaminidase
activity in activi ty units , and hexosaminidase A only as a perce nt of
total (that is to say, hexosaminidase A
was not presented in ac tivity units) .
Whereas the range of hexosaminidase
A of heterozygotes expressed as a perce nt of total does not overlap with the
range for controls in th at series, the
range of hexosaminidase A in ac tivity
units does overl ap with that of controls, as is shown in later reportS from
other laboratories. See M. M. Kaback
et al. , "Automated Thermal Frac tionati on of Serum Hexosaminidase:
Effects of Alteration in Reaction
Variables and Implicati ons for Tay Sachs Disease Heterozygote Screening," Progress in Clinical and
Biological Research 18 (1977 ):
197 - 212. This latter poi nt does not
obviate the di agnostic use of hexosaminidase A as percent of total, but
it should serve as a furth er cautionary
note in the diagnostic use of complicated laboratory data.

Patient Name : Wife
Serum hexosaminidase ,
total
Serum hexosaminidase A

RANGES
Total Hexosaminidase
Range

Hexosaminidase A
% of Total Range

333- 77 5
288-644

49-68
26- 45

Children with Tay-Sachs
disease

284- 1232

0-4

Other patients

401-2652

Controls
Heterozygotes

19-79
Note : 20% of women on birth control pills, pregnant women , patients with
diabetes, myocardial infarct, hepatitis , or pancreatitis may have a high
total hexosaminidase with low percentage of hexosaminidase A. Heterozygotes have about 65 % of normal levels ofhexosaminidase A. However,
the gap between values from normals and heterozygotes is narrow; thus as
more individuals are studied , an overlap in values may occur.

Source : This report form is based on). S. O'Brien et al. , " Tay-Sachs Disease. "
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First, was the laboratory test result wrong? It is possible for an outand-out error to occur in any procedure. There are certain safeguards
that a laboratory builds into its routine to prevent that. Over and above
the observance of good laboratory practice a laboratory is required to
perform internal quality control checks every time a patient specimen
or batch of specimens is run. The laboratory did test serum from normal controls and a Tay-Sachs carrier in this way. The hexosaminidase
A, percent of total results with these controls clustered within an acceptable dispersion around the target values of 55% and 40%, respectively. In addition, an artificial standard with a target value of 25
nmol/ml was analyzed with each batch, and it, too, was accurately determined. There was no drift or wide fluctuation of results during the
period before, during, and after the specimens of interest were tested,
indicating the absence of systematic or random error occurring with the
test at that time. Therefore it can be assumed, there being no evidence
to the contrary, that the results on the specimens were correct.
The concept of'' correctness'' subsumes the concepts of accuracy and
precision . It is best to be accurate and precise, but it is possible to be
either one or the other. This is illustrated by Figure 1. These terms have
very specific meanings in laboratory science. Accuracy refers to the approximation of the analytic result to the true value. The use of standards and controls described above satisfies the usual criteria for accuracy
in this case. Precision refers to the repeatability of an analytic procedure.
Each laboratory test has a known precision, or imprecision. In the
case of hexosaminidase levels it is approximately. ± 15%. This is the
2 standard deviation (2 S.D.) spread of results around the mean from
repeated analysis of the same specimen. Two S.D.'s are defined as the
limits that include 95% of the observations. It translates to this kind
of understanding of any particular result: If a test has a precision of
± 15%, an analytic determination of, for example, 100 arbitrary units
is really 100 ± 15 units with 95% probability. That is, if the same
specimen were analyzed repeatedly, 95% of the time the result would
fall between 85 and 115. The 15% imprecision of the hexosaminidase
test is about at the state of the art. It is not as good as many tests, but
it is much better than others. What it means in this particular case is
that the result of "50% hexosaminidase A" is really 50% ± 7.5%;
i.e., if the same specimen were tested 100 times , 95% of the results
would be between 42 .5% and 57.5%. The more precise a test, the more
confidence can be placed in a result close to a normal range limit. The
less precise the test or the closer to the normal range limit, the less
significance can be attached to results. So, in this particular case, with
a result that is not analytically wrong and is as good as a laboratory can
perform, a definitive conclusion about the subject's carrier status cannot be made because of the intrinsic precision limits of the test procedure itself.
Second, what is the meaning of normal range anyway? First note that
Figure 1.

0
..

Accurate and precise
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Precise
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even the laboratory report shown in Table 1 does not use the term' 'normal range," but "adult normals." Another phrase that replaces "normal range" on the report form of some laboratories is "reference interval.'' Each version aims to avoid the suggestion that the quoted range
is synonymous with normality in the sense of desirability or that it is
indicative of good health.
The normal range is a statistical concept, and the words themselves
are derived from the most fundamental property of populations, the
normal distribution. It is not wasted printer's ink to display a normal
distribution in its classic form (see Figure 2). Any measurable
characteristic will distribute about a calculable mean. If the values form
a "bell-shaped" curve, as shown in the figure, or if they are skewed
as in a nonparametric distribution, the standard deviation can still be
calculated. These measures quantify nothing more or less than the individual variations that characterize almost every property in biology.
By definition, 1, 2, and 3 standard deviations are the limits around
the mean that embrace 66 .3%, 95.4%, and 99.7%, respectively, of
all the values that were measured. By convention, the normal range
in clinical laboratories, and in many other fields, is taken as the 2 S.D.
limit. An example may be helpful: Serum uric acid levels are highly
diagnostic of gout. By definition, 95 of 100 individuals who do not
have gout will have blood uric acid levels within the stated normal range
limits. This also means that 5 in 100 people without gout will have
blood uric acid results outside the normal range. A range of blood uric
acid results can also be obtained for gouty patients. It will have a mean
and, by definition, a normal range limit that embraces 95% of the
population studied . Also, therefore, by definition, 2. 5% of all people
with gout will have blood uric acid results below the lower limit of that
Figure 2. Normal range distribution curve .

I
-3

-2

-1

Mean

+1

+2

+3

Standard Deviation
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range .
The ranges of results actually found for any constituent of blood
almost always show overlap between those without and those with the
disease of interest. A blood uric acid slightly higher than the quoted
normal range could be from one of the 2. 5% of nongou ty people who,
by definition, fall above the limit. Or a blood uric acid just below the
upper limit of the quoted normal range could be from one of the 2. 5%
of gouty patients who, by definition, fall below the range limit that
was defined to include only 95% of all patients with gout. Since the
ranges overlap, a blood uric acid just at or within the upper limit of
the normal range could be from a gouty or a nongouty subject.
It is intuitively obvious, and has been rigorously proved ,7 that the
closer a result is to the stated normal range limit, the more likely it
is to come from an abnormal individual, i.e., one with the disorder
of interest and who is therefore part of the diseased population that
was not evaluated precisely in order to establish the normal range. If
a test has any diagnostic discriminatory value, it must have ranges that
do not totally overlap between people with and without the disease .
It follows that the closer a result is to the middle of the normal range,
the more confidently one can assert that it came from a person without
the disease . Quantitative statements can be made for expressing such
probabilities, but they require knowledge of the number of normal and
diseased persons in the overall population. For example, if diabetics
and nondiabetics were in exactly equal numbers in a hypothetical
population, and the upper limit of the normal range for nondiabetics
corresponded exactly to the lower limit of the normal range for diabetics,
then a result exactly at that common range limit would have a 50%
chance of coming from a diabetic and a 50% chance of coming from
a nondiabetic. If the result were slightly lower than the upper limit
of the normal range, the probability would increase that it came from
a nondiabetic and proportionately decrease that it came from a diabetic,
and so on .
Since in most cases overall population frequencies are not known and
such probability statements cannot be made, physicians are taught to
recognize the consequences of the general principles, look at each case
individually, and act accordingly.
Third, what is the proper interpretation of the findings in this case?
A full interpretation of the result "50% hexosaminidase A" for the
wife should not have simply noted it to be within the low end of the
quoted range for controls, above the high end of the quoted range for
heterozygotes, and concluded that therefore the sample came from
someone who could not be a heterozygous carrier ofTay-Sachs. On the
basis of the intrinsic imprecision of the tests alone, it should have been
appreciated that the result could well fall into the range for
heterozygotes. On the basis of the definition of normal range alone,
it should have been recognized that a substantial number of
heterozygotes fall outside the quoted limits. The note included on the
report form was intended to alert the family physician to the overlapping of ranges that was predicted, and which was later substantiated,
between proved heterozygotes and noncarrier controls. An informed
and prudent approach, considering the great significance attached to
this particular result, would have been at least to repeat the test. If just
about the same result was obtained, judicious counseling would have
emphasized the possibility that the wife was a carrier. Other steps could
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then have been taken to establish whether the subsequent embryo was
afflicted with Tay-Sachs disease, and a "wrongful life" could have been
avoided.

The legal precedent: Wrongful life
In the legal suit under discussion, the clinical laboratory became the
prime target of the plaintiffs. Why? It had very large liability insurance
coverage. The physician's malpractice insurance would have covered only
a fraction of the amount of damages sought. The suit, brought in 1978,
was the first based on this version of the "wrongful life" theory. A
lower court in California ruled that the afflicted child could sue on that
basis, and the decision was allowed to stand by the state supreme court.
Neither court ruled on the particulars of the case, either to establish
responsibility or to determine damages. But before those very issues
were brought before the Superior Court of the State of California a settlement was made. The laboratory paid the plaintiffs $1. 5 million.
The consequences of this case are uncertain at this time. Bad reporting in the medical and lay press has also beclouded the issue. For example, Newsweek reported this case in an article entitled "Suing for
Being Born. "s It stated, "A genetic laboratory analyzed their blood
and declared that neither was a Tay-Sachs carrier. The lab was wrong.''
In fact, and unfortunately for the cause of truth, Newsweek was wrong.
The lab did not declare anything. It reported numbers to a physician
who had requested a test, and there is no evidence that ''the lab was
wrong'' in the results they rendered . Newsweek went on to note that
other cases based on wrongful life can be expected. It mentioned the
case of a normal birth following an unsuccessful vasectomy. It also mentioned a child who was born deaf after an apparently inaccurate assessment of a hereditary factor in an older sibling. The American Medical
News has recently reported the award in a wrongful life suit of $625,000
to a 3-year-old boy with multiple birth defects.9 He was born to an Air
Force recruit whom military physicians failed to advise properly about
measles.
Especially in the case of a failed vasectomy, the theory of wrongful
life threatens to undo precedents of many years standing which hold
that damages are not recoverable in the case of the birth of a normal
child. Basic legal theories are involved. Is there a breach of contract
or breach of implied warranty for insured sterility after a vasectomy or
tubal ligation? Is life an overriding value and awarding damages even
for the costs of pregnancy and delivery contrary to public policy? Even
if such damages are allowed, should they be extended to include the
costs of raising and educating a normal child? If so, is there a definable
and recoverable dollar amount that balances the benefits of raising and
enjoying a child and the costs and problems associated with that experience? These questions have been well discussed in an article by the
general counsel of the American." Medical Association. 10
Further complicating the issue is legislative action in California. According to a recent article, 11 a measure has been approved that would
bar a child with birth defects from suing his parents for being born.
But the bill ''does not prevent a child from suing a laboratory in a similar
case," i.e. , a case in which the parents had known they were carriers
of a heritable disorder and had gone ahead with the birth anyway. "It
also bars the laboratory from using the parent's knowledge and refusal

https://surface.syr.edu/suscholar/vol4/iss1/7
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to get an abortion as a defense against a suit by the child. ' ' This kind
of convoluted legislative thinking should make any laboratory director
without a deep self-destructive tendency discontinue testing for inheritable disorders. Can this be progress?

Legislative abuse of the normal range
It is now in vogue to identify medical care costs as a target for reduced support by government. Overall, medical costs are demonstrably
rising by every measure: percent of GNP , $/year, patient cost/hospital
day, etc. The cost of medical care is increasing faster than the inflation
rate , which is, after all, merely the average of many components. But
it was not very long ago that the government, presumably representing
the people it serves , chose to support more medical care for more
people through increased expenditures. Medicare, Medicaid, Workmen's
Compensation, and numerous programs directed at particular diseases ,
e.g. , kidney disorders (via renal dialysis funding), cancer, and hypertension, were brought into being. After all, until two decades ago our
government provided virtually no such support, while socialist and even
democratic states who did were perceived as doing the right thing. Even
now, on a per capita basis our government support for direct medical
care is less than many other nations . Regardless, medical care costs are
now subject to critical review with the objective of reducing current levels
of support by the very bureaucracy that was brought into being to deliver
that support not so long ago . I, for one , am not clear whose bidding
is being done now. There has never been anything like a national
referendum on the subject of the relative level of funding desired for
medical care . It has not been openly discussed in election debates , in
letters of inquiry from congressmen to their constituents, or by other
means of soliciting the opinion of a broad base of the population.
Nonetheless, deep in section 108 of the Tax Equity and Fiscal Responsibility Act of 1982 , Section 1887, the Social Security Act is modified
for the purpose of reducing medical care expenditures . Rules were
drafted to implement these changes by the Health Care Financing Administration (HCFA) and published in the Federal Register on 1 October 1982 . Some of these rules reveal an appalling ignorance of the
practices they will regulate. Particularly meretricious are regulations
ostensibly intended to limit unnecessary medical consultations in the
interpretation of laboratory tests. These regulations flagrantly abuse the
concept of normal range. Far from being an arcane detail of little importance to society in general, it directly and adversely affects the approximately 4 million of us who , each day, have laboratory tests. I will
explain and illustrate this issue which, I submit, is within the intellectual reach of any thoughtful person, even the Federal rules writers who
have neglected, ignored , or misunderstood it .

I

n order for a pathologist, who is a specialized physician responsible for laboratory testing, to be reimbursed for his professional services relating to a patient's test result, a consultation with the physician who ordered the test must meet four new conditions. Among them,
according to the rules put forth in Section 405 .556 (b) , are that the
consultation "must . . . relate to a test outside normal range(s) ." Now,
pathologists can no more be expected to perform without compensation than any other member of society would be expected to deliver
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goods or services without pay. So as written the new rules would effectively deny payment for, and therefore eliminate consultation on, results
that are not outside the nominal normal range. 12
Consider some of the consequences of this restriction. The entire constellation of suffering and expense described previously in the case of
the child with Tay-Sachs disease would all have been avoided if proper
interpretation had been obtained of laboratory tests that were not outside the normal range. In the discussion of that case, I emphasized the
arbitrary limit setting that, by a formal convention only, has designated
certain values as normal range limits. The term normal range is technical
and not intuitive. It does not mean that medical desirability or the
absence of disease is limited to results within the normal limits. It does
not necessarily attribute abnormality or medical undesirability to results
outside the normal limits. It is a purely statistical concept that has meaning in a special sense that may or may not be important for a particular
patient. I also emphasized that the significance that can be attached
to any numerical result from a quantitative test is dependent on the
intrinsic error of the method. Therefore, test results that fall within the
nominal normal range limits can wei/lead to an important medical
diagnosis of disease and consequent therapeutic decisions.

0

ther fundamental concepts involved in the interpretation of
laboratory tests are also violated by the simplistic rule written
by HCFA. The first of these is individual variation.13 The
range of results with any particular test is much narrower for a single
individual than for a large group of individuals. This truism follows
from the inescapable workings of statistics but translates into very direct
human consequences. For example, one may have a blood urea nitrogen
(BUN) level of 12 mg/ dl ± 2 mg/ dl day in, day out for years. The
BUN reflects the effective function of the kidneys in removing
nitrogenous wastes left over from the metabolism of protein and the
breakdown of tissue that is constantly occurring in the wear and tear
of life. Other perfectly healthy people with perfectly well-functioning
kidneys may show BUNs of 8, 10, 15, or 20 mg/ dl with a similar narrow range of day-to-day fluctuation. This is predictable on the basis
of individual variation. It is characteristic of virtually all biological
phenomena and leads to the bell-shaped parametric or other nonparametric distributions from which means and standard deviations are
calculated for whole populations. Normal range limits for BUN are
defined to include, arbitrarily, 95% of all people without kidney disease.
That normal range is substantially wider than the range of results within
which any single healthy individual fluctuates. Therefore, a significant
change from normal kidney function to abnormal kidney function will
first elevate a person's BUN above his normal range but within the
population's normal range. Only the few individuals in the healthy
population with BUNs at the upper end of the normal range will show
elevation beyond the normal range limit at the first appearance of kidney
disease. Doctors know the values for many constituents of their patients'
blood or urine from previous tests. "Screening" testing has been widely
advocated for that very purpose. Therefore, it is incorrect, improper,
and counterproductive to construe what may well be a significant change
for an individual as ineligible for review by an expert because it still
falls within the normal limits of the broader population.

https://surface.syr.edu/suscholar/vol4/iss1/7

12. At the present time it appears
that this rule will be included in those
finally published by HCFA. Its impact
cannot be gauged until we see
whether some modifications are introduced and the manner and extent of
its enforcement.

What is normal in a
general population may
nevertheless be abnormal
in some individuals.
13. D. S. Young, "Biological
Variability," in Chemical Diagnosis of
Disease, ed. S. S. Brown, F. L.
Mitchell, and D. S. Young (Amsterdam: Elsevier/North Holland, 1979),
pp. 1-115.
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Trending patterns ...
Since disease originates in
a healthy body, the first
indication of tflness occurs in the normal range,
just as occasional sneezing may indicate the
beginnings of a bad case
of flu.

In blood banking there
are no such things as
normal or abnormal
ranges.
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Another basic phenomenon observed in the monitoring of a patient's
laboratory results that deserves, but would be denied, consideration is
''trending'' within normal limits . Even within the narrower range of
results found for a single individual , important trends may occur that
need to be further investigated and understood. It is intuitively obvious that a change big enough to place a result outside normal limits
begins with small changes that move in that direction. Astute observation of such trends is the hallmark of good medical practice . From it
the physician can be proud and the patient saved much suffering . For
example, in the field of endocrinology it is now possible to perform
very precise measurements of circulating thyroid hormones . Disorders
of the thyroid usually develop over relatively long time spans . Thyroid
hormone levels are regulated by feedback inhibition systems so that very
rapid changes are rarely seen . There is little diurnal or other periodic
fluctuation in the serum levels of those hormones . Therefore a slow but
steady increase or decrease in thyroid hormone levels, even if small,
can constitute objective evidence in support of an early diagnosis of
hyper- or hypothyroidism. All the advantages of modern therapy can
then be employed. This example is not a rarity or a fiction concocted
to support weak arguments. Along with the others already mentioned
it occurs often enough in the ordinary practice of clinical pathology that
its prohibition by regulation needs to be exposed as contrary to science
and to the best interests of patients.

H

CFA's rules ignore even much simpler realities than those mentioned above. For example, in the field of blood banking
there is no such thing as a normal range . Yet it is in this area
that some of the most important consultations between pathologists
and clinicians occur. Modern blood banking has responded to the requirements of daring new forms of surgery. Laboratory tests are of the
utmost direct importance in the care of such patients. But the concepts
of normal range are not applicable at all to such testing. Characterization of the antigen composition of donor and recipient blood allows
for compatible transfusions entirely without reference to normal ranges .
By definition, no blood banking result , including workups of transfusion reactions, can be outside the normal range.
A further example is provided by the need for a laboratory specialist's
appropriate consultation in the field of coagulation. Specific components
are now available from blood banks for the correction of coagulation
disorders that only recently led to fatal bleeding. This is a complicated
and rapidly progressing field . New aspects of the reaction cascade of
more than a dozen factors that culminates in a successful clot are being
discovered and named every year. A defective or deficient component
can influence many steps, each tested separately, that occur in this
cascade. Few practitioners can keep abreast of the latest information,
and they rely on the clinical pathologist. In the workup of a "bleeder"
many tests are usually performed, and an interpretation is made on the
basis of the entire picture they provide. Perhaps only one of ten will
be abnormal, but all ten must be performed and considered to identify where and how to intervene with the correct component replacement therapy . It is patently impossible to limit a consultation in such
a situation to the abnormal result only.
Perhaps the most common laboratory test for clotting, the prothrom-
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bin time, is indicative of a serious problem precisely when the result
is normal and not when it is abnormal. This is not semantic sleight
of hand. The prothrombin time is ordered to monitor the effectiveness
of anticoagulant therapy that is commonly employed in patients with
heart attacks, strokes, and thromboses. The danger represented by normal clotting in these conditions is treated by prolonging the coagulation of blood as measured by this in vitro test. The therapeutic objective is, therefore, to regulate the dose of anticoagulant to keep the test
result outside the normal range. Under these conditions, a result within
the normal range is an indication of a true medical emergency. The
literal application ofHCFA's rule in such circumstances would certainly
invite a form of negligence no one really wants.
The entire field of toxicologic testing and therapeutic drug monitoring employs definitions of normal range, therapeutic range, and toxic
range that have everything to do with good medicine and nothing to
do with HCFA's regulation. Drugs, of course, have no normal range
in untreated, well populations. Therapeutically active substances that
are naturally present in very low concentrations, such as lithium (which
is used in pharmacologic doses for control of manic depression), have
a normal range of no particular interest. Toxic materials such as alcohol
are important at some concentrations but not at others. Especially important in the proper utilization of such test results is recognition of
the patient's individuality. Often pathologists act as consultants on particular patients and particular circumstances. For example, idiosyncratic
reactions are particularly common with some drugs and in some patients. It is inconceivable that regulations could ever be properly drafted
to cover what constitutes a consultable result in the case of a drug whose
blood level varies several orders of magnitude in the course of its cycle
of absorption and excretion. A given blood level found early after administration and the same level found at the time expected for it to
peak would obviously have enormously different implications. For example, an acetaminophen (Tylenol) level of lOO~g/ml is five times
the upper limit of the quoted therapeutic range, but well below the
level ordinarily found within four hours of ingestion of nontoxic amounts
of the drug. Many drugs or toxins can be tolerated by some individuals
at levels that would be deadly to others. This happens because of idiosyncratic reactions that go beyond ordinary interindividual variations. Such
reactions represent some distinctly different metabolism of the agent
in one person or class of persons than in the majority. Certain disease
states inhibit normal processes of detoxification. Just these kinds of problems are reviewed by the pathology staff day by day and patient by
patient in our and probably every good clinical laboratory . The
pathologist knows individual patients by their reactions and susceptibilities even if he never sees them face-to-face. 14 His consultation on
behalf of such problem patients would be noncompensable by HCF A
rules because it defies codification.
In microbiology testing, the concept of normal range is also totally
inapplicable. Laboratories may quote "normal flora" for particular body
sites, but the same organisms that are innocuous under some conditions can be serious pathogens under others. Consider that pneumococcus and hemophilis influenza are found in the throat cultures of many
healthy people. But in a debilitated or immunocompromised host they
can cause fulminant disease. Almost every opportunistic fungus can be

https://surface.syr.edu/suscholar/vol4/iss1/7

In many medical
emergencies, test results
characteristically fall in
the normal range.

In the case of drug
therapy, it is dangerous
to ignore the patient's
individuality by applying
the normal range
concept.

14. P. Winkel , " Reference Values,"
in Clinical Diagnosis and Management
by Laboratory Methods, ed. ). B.
Henry (Philadelphia: Saunders, 1979),
pp. 29-53 .
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found in normal people, where it is held in check. The same organism
can disseminate and kill the susceptible host.

Conclusions
Normal range is a meaningless concept in so many areas of the clinical
laboratory that one is tempted to deal with HCFA's misuse of it by
an evasive semantic mechanism. Since the definition of normal range
has arbitrarily been set at 2 standard deviations to encompass 95% of
the population, why not change the definition to 1 standard deviation?
Then only 66% of the population would be normal, and the opportunity to consult would extend to a larger potential number of problem cases. Similarly, pathologists could adopt new conventions to state
the normal range for infectious organisms as "none" and escape any
restrictions on consulting about any microbiological results. The same
could be done for all toxicology and therapeutic drug monitoring results.
Certainly the profession could outdefine the regulators in blood banking, coagulation testing, or any other part of the clinical laboratory's
repertoire. But such exercises would go against the proper scientific
understanding and good medical practice that should be advocated by
organized medicine on behalf of its members and their patients.
After all, it is the legislator who should comprehend and deal with
reality, no matter how complicated . The misapprehension of reality
manifested by a small but important phrase buried in the depths of
a bill that nobody will study or complain about is, perhaps, indicative
of a more general shortcoming in society. I refer not only to the too
easy way in which we grant powers and acquiesce to the published word
provided that it appears in the Federal Register. We passively accept
civil authorities that go beyond the intent of statutes, exceed their
knowledge, and establish harmful public policies. Our acceptance
betrays a deeper, more dangerous set of attitudes characteristic not
only of our authorities and lawmakers but also of the public whom they
serve, ourselves, in other words. The life of the body is no less complex
than the life of the mind. While it would be reassuring and convenient to solve problems simply and neatly, be they physical or
metaphysical, most problems do not admit of simple solution. Life,
whether of the individual cell or of the body politic, is not governed
by a system of sharp contrasts in black and white, but by a continuum
of shades of gray. Except in a statistical sense, there is no such thing
as normalcy; there is only a range of behavior-biological, psychological,
intellectual-which under specific circumstances may be described as
desirable and, under others, as undesirable. To insist on simple distinctions when circumstances dictate complexity and even ambiguity is to
abuse the scientific concepts. In the hospital this attitude can result in
incalculable personal suffering. In the world of ideas, this attitude constitutes the very denial of the richness of life itself.
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